4.8 Article

High-Yielding Separation and Collection of Plasma from Whole Blood Using Passive Filtration

期刊

ANALYTICAL CHEMISTRY
卷 92, 期 24, 页码 16245-16252

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c04127

关键词

-

资金

  1. Drummond Scientific
  2. Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP)
  3. Tufts Launchpad Accelerator project

向作者/读者索取更多资源

Lateral flow tests and hand-held analyzers facilitate diagnostic testing in resource limited settings and at the point-of-care. However, many of these devices require sample preparation such as plasma separation to remove cells and isolate the liquid portion of blood. Specifically, the separation of plasma from blood is necessary for routine health assessments such as comprehensive metabolic panels and chronic HIV viral load monitoring. Away from laboratories, this type of processing has been addressed by unconventional, hand-operated centrifuge devices (high volume) or plasma separation membranes (PSM) coupled with lateral flow tests (low volume). Herein, we describe a device that separates and stores plasma from undiluted blood using only passive filtration in less than 10 min. Integrating a PSM with a prefilter and absorbent material yields a 3-fold increase in separation efficiency compared to similar devices using passive filtration. We demonstrate the reproducibility of our device across the physiological range of hematocrits (20-50%) with an average recovered plasma volume of 61.7 +/- 2.6 mu L. Maximum separation efficiency (53.8%, 65.6 +/- 3.9 mu L plasma) was achieved for a sample of whole blood (30% hematocrit) in 10 min. We evaluate the purity of our plasma sample by quantitation of hemoglobin and report hemolysis as either minimal (<= 5%) or undetectable (<= 1%). Specific recovery of human IgG, IFN-gamma, and HIV-1 RNA indicate the diagnostic utility of plasma obtained from our device is unchanged compared to plasma obtained via centrifugation. Finally, we demonstrate the use of recovered plasma, applied via stamping, to successfully conduct a commercial lateral flow immunochromatographic assay for tetanus antibodies. This device platform is capable of producing pure plasma samples from blood to facilitate tests in resource limited settings to improve access to healthcare.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据